Pricing & Access· May 26, 2026 · 7 min read
Veppanu (vepdegestrant) coverage guide: the first PROTAC degrader for ER+/HER2− breast cancer
By Ran Chen#PROTAC#Breast Cancer#Companion Diagnostic
Topic
NCCN Guidelines
National Comprehensive Cancer Network guideline updates, Category 1 and 2A recommendations, and their role in prior authorization and appeals.